Assessment of knowledge of healthcare professionals of diabetes mellitus technology (continuous glucose monitoring systems and insulin pump therapy). The study is a cross-sectional, quantitative study at a tertiary university hospital in Thessaloniki, Greece
Data will be collected using a standardized questionnaire. This questionnaire is based on a review of the relevant literature on diabetes management and related technologies. The final instrument consists of 37 closed-ended items. It was organized into four main sections, covering demographic characteristics, knowledge of diabetes mellitus, knowledge of insulin therapy and insulin pump use, and knowledge of CGM systems. Demographics will be also collected along with diabetes knowledge questions and 2 sections (1 for insulin pumps and 1 for continuous glucose monitoring).
Study Type
OBSERVATIONAL
Enrollment
112
A standardized questionnaire developed specifically based on a review of the relevant literature on diabetes management and related technologies
University General of Thessaloniki AHEPA
Thessaloniki, Greece
RECRUITINGKnowledge of Diabetes Mellitus aspects
Questions on diabetes types, diagnostic criteria, risk factors for hypo- and hyperglycemia, symptom recognition, and glycemic targets.
Time frame: Through study completion, an average of 1 year and 3 months
knowledge on insulin use
The instrument was a questionnaire of 37 closed ended items organized in 4 sections covering demographic characteristics, knowledge of diabetes mellitus, knowledge of insulin therapy and insulin pump use, and knowledge of CGM systems. The questions for insulin use covered the knowledge of healthcare professionals on insulin regimens, dose calculation and administration, principles and benefits of insulin pump therapy, potential complications and appropriate actions in case of device malfunction.
Time frame: Through study completion, an average of 1 year and 3 months
Knowledge of healthcare professionals on continuous glucose monitoring systems
Questions on system function, accuracy, indications for use, contribution to glycemic control, sensor placement and common issues during use.
Time frame: Through study completion, an average of 1 year and 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.